FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Surmodics's Free Cash Flow for the
three
months ended in Jun. 2025 was $0.9 Mil. Surmodics's Revenue for the
three
months ended in Jun. 2025 was $29.6 Mil. Therefore, Surmodics's FCF Margin % for the quarter that ended in Jun. 2025 was 3.06%.
The historical rank and industry rank for Surmodics's FCF Margin % or its related term are showing as below:
SRDX'
s FCF Margin % Range Over the Past 10 Years
Min: -20.6 Med: 9.54 Max: 24.54
Current: -2.94
During the past 13 years, the highest FCF Margin % of Surmodics was 24.54%. The lowest was -20.60%. And the median was 9.54%.
SRDX's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.1
vs SRDX: -2.94
Surmodics FCF Margin % Related Terms
Surmodics FCF Margin % Historical Data
* Premium members only.
The historical data trend for Surmodics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surmodics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surmodics FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Surmodics's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics (SRDX) has a FCF Margin % of 3.06% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Surmodics and its competitors. This is 68% below median its historical median of 9.54.
Is Surmodics' FCF Margin % too high?
Surmodics' current FCF Margin % of 3.06% is 68% below median its 10-year median of 9.54. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' FCF Margin % compare to CBLL and OFIX?
Surmodics' FCF Margin % of 3.06% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Surmodics and its competitors. Surmodics's current FCF Margin % is 3.06%, which is 68% below median its own 10-year median of 9.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current FCF Margin % of 3.06%. The stock's GF Value™ is $32.10, compared to a current price of $42.98 — trading 33.9% above its estimated fair value. The current FCF Margin % is 3.06%, which is 68% below median its 10-year median of 9.54. Surmodics' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Surmodics (SRDX), the current FCF Margin % is 3.06% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surmodics (SRDX) Overvalued in 2026?
Based on GuruFocus' analysis, Surmodics stock appears to be overvalued.
The current stock price of $42.98 is trading 33.9% above its estimated GF Value™ of $32.10.
Key valuation signals for SRDX:
FCF Margin %: 3.06% (68% below median its 10-year median of 9.54)
GF Value™: $32.10 vs. price of $42.98 (33.9% above fair value)
No single metric tells the full story. See the SRDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score
Get the complete analysis for SRDX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRDX has been successfully added to your 
